Interim report Q3 2026

Storskogen’s third-quarter net sales rose 4% to SEK 8,330 million, while adjusted EBITA increased 6% to SEK 806 million. Adjusted EBITA margin improved to 9.7% from 9.5%; the CEO said organic growth and acquisitions contributed across all business areas.

Analysis

The useful signal is that growth was not solely acquisition-dependent: organic contribution alongside acquired growth reduces the risk that reported expansion is being maintained only by deal volume. However, the small margin improvement relative to sales growth points to only modest incremental operating leverage so far; it does not establish that acquisitions are earning attractive returns or translating into cash. For an acquisition-led group, the next question is whether growth converts into free cash flow after integration costs and financing, not simply whether EBITA rises.

Near term, the release supports a mildly constructive read, but the excerpt is too limited to justify chasing the shares without the market reaction, valuation, balance-sheet figures, and full-year outlook. Over the next 1–3 months, check organic growth by business area, cash conversion, net debt and any guidance changes. Over 6–18 months, sustained organic growth with stable or rising margins would strengthen the case that the portfolio can grow without relying on increasingly costly acquisitions. Conversely, weaker cash conversion or leverage rising faster than operating earnings would expose the group to higher funding costs and constrain deal capacity. The thesis is falsified by a reversal in organic growth, margin giveback, or deterioration in net debt/cash conversion.

Key Decisions for Investors

• Maintain a watchlist-positive stance rather than initiating a large event-driven position: the operating direction is encouraging, but the excerpt does not establish valuation, cash generation, or balance-sheet support.
• Before adding STOR.B, verify the full report for organic growth by business area, free-cash-flow conversion, net debt and financing costs, and full-year guidance; treat deterioration in cash conversion or leverage as a reason to stand aside.
• For a 1–3 month catalyst, monitor subsequent reporting for organic growth and margin durability. A reversal in either would undermine the quality-of-growth thesis; continued improvement alongside stable leverage would support reassessment.